195 related articles for article (PubMed ID: 6096860)
1. DNA damage related to increased hydrogen peroxide generation by hypolipidemic drug-induced liver peroxisomes.
Fahl WE; Lalwani ND; Watanabe T; Goel SK; Reddy JK
Proc Natl Acad Sci U S A; 1984 Dec; 81(24):7827-30. PubMed ID: 6096860
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of hypolipidemic peroxisome proliferator administration on hepatic hydrogen peroxide metabolism in rats.
Tamura H; Iida T; Watanabe T; Suga T
Carcinogenesis; 1990 Mar; 11(3):445-50. PubMed ID: 2311188
[TBL] [Abstract][Full Text] [Related]
3. Differential induction and regulation of peroxisomal enzymes: predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens.
Nemali MR; Reddy MK; Usuda N; Reddy PG; Comeau LD; Rao MS; Reddy JK
Toxicol Appl Pharmacol; 1989 Jan; 97(1):72-87. PubMed ID: 2916237
[TBL] [Abstract][Full Text] [Related]
4. In vitro steady-state levels of hydrogen peroxide after exposure of male F344 rats and female B6C3F1 mice to hepatic peroxisome proliferators.
Tomaszewski KE; Agarwal DK; Melnick RL
Carcinogenesis; 1986 Nov; 7(11):1871-6. PubMed ID: 3769136
[TBL] [Abstract][Full Text] [Related]
5. Induction of peroxisomes by treatment with perfluorooctanoate does not increase rates of H2O2 production in intact liver.
Handler JA; Seed CB; Bradford BU; Thurman RG
Toxicol Lett; 1992 Jan; 60(1):61-8. PubMed ID: 1539182
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of peroxisome proliferators on the balance between hydrogen peroxide-generating and scavenging capacities in the liver of Fischer-344 rats.
Tamura H; Iida T; Watanabe T; Suga T
Toxicology; 1990 Aug; 63(2):199-213. PubMed ID: 2399535
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of selected hypolipidemic agents for the induction of peroxisomal enzymes and peroxisome proliferation in the rat liver.
Lalwani ND; Reddy MK; Qureshi SA; Sirtori CR; Abiko Y; Reddy JK
Hum Toxicol; 1983 Jan; 2(1):27-48. PubMed ID: 6840792
[TBL] [Abstract][Full Text] [Related]
8. Development of hepatocellular carcinomas and increased peroxisomal fatty acid beta-oxidation in rats fed [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643) in the semipurified diet.
Lalwani ND; Reddy MK; Qureshi SA; Reddy JK
Carcinogenesis; 1981; 2(7):645-50. PubMed ID: 7273344
[TBL] [Abstract][Full Text] [Related]
9. Proliferation of peroxisomes without simultaneous induction of the peroxisomal fatty acid beta-oxidation.
Baumgart E; Völkl A; Pill J; Fahimi HD
FEBS Lett; 1990 May; 264(1):5-9. PubMed ID: 2338145
[TBL] [Abstract][Full Text] [Related]
10. Oxidative DNA damage caused by persistent peroxisome proliferation: its role in hepatocarcinogenesis.
Reddy JK; Rao MS
Mutat Res; 1989 Sep; 214(1):63-8. PubMed ID: 2671702
[TBL] [Abstract][Full Text] [Related]
11. Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis.
Ashby J; Brady A; Elcombe CR; Elliott BM; Ishmael J; Odum J; Tugwood JD; Kettle S; Purchase IF
Hum Exp Toxicol; 1994 Nov; 13 Suppl 2():S1-117. PubMed ID: 7857698
[TBL] [Abstract][Full Text] [Related]
12. Specificity in the action of hypolipidemic drugs: increase of peroxisomal beta-oxidation largely dissociated from hepatomegaly and peroxisome proliferation in the rat.
Lazarow PB; Shio H; Leroy-Houyet MA
J Lipid Res; 1982 Feb; 23(2):317-26. PubMed ID: 7077146
[TBL] [Abstract][Full Text] [Related]
13. Dichloroacetic acid and trichloroacetic acid-induced DNA strand breaks are independent of peroxisome proliferation.
Nelson MA; Lansing AJ; Sanchez IM; Bull RJ; Springer DL
Toxicology; 1989 Oct; 58(3):239-48. PubMed ID: 2799828
[TBL] [Abstract][Full Text] [Related]
14. Proliferation of myocardial peroxisomes caused by several agents and conditions.
Zipper J
J Mol Cell Cardiol; 1997 Jan; 29(1):149-61. PubMed ID: 9040030
[TBL] [Abstract][Full Text] [Related]
15. Partial purification and immunoreactivity of an 80 000-molecular-weight polypeptide associated with peroxisome proliferation in rat liver.
Reddy MK; Hollenberg PF; Reddy JK
Biochem J; 1980 Jun; 188(3):731-40. PubMed ID: 6781475
[TBL] [Abstract][Full Text] [Related]
16. Studies by the National Toxicology Program on di(2-ethylhexyl)phthalate.
Melnick RL; Morrissey RE; Tomaszewski KE
Toxicol Ind Health; 1987 Jun; 3(2):99-118. PubMed ID: 3617073
[TBL] [Abstract][Full Text] [Related]
17. Paradoxical increase in peroxisomal cyanide-insensitive respiration following dietary exposure to WY-14,643 in the perfused liver.
Bojes HK; Sausen PJ; Cattley RC; Keller BJ; Thurman RG
Toxicol Appl Pharmacol; 1996 Apr; 137(2):202-9. PubMed ID: 8661345
[TBL] [Abstract][Full Text] [Related]
18. Induction of fatty acid beta-oxidation and peroxisome proliferation in the liver of rhesus monkeys by DL-040, a new hypolipidemic agent.
Lalwani ND; Reddy MK; Ghosh S; Barnard SD; Molello JA; Reddy JK
Biochem Pharmacol; 1985 Oct; 34(19):3473-82. PubMed ID: 3840374
[TBL] [Abstract][Full Text] [Related]
19. Role of fatty acyl coenzyme A oxidase in the efflux of oxidized glutathione from perfused livers of rats treated with the peroxisome proliferator nafenopin.
Conway JG; Neptun DA; Garvey LK; Popp JA
Cancer Res; 1987 Sep; 47(18):4795-800. PubMed ID: 3621175
[TBL] [Abstract][Full Text] [Related]
20. Expression of liver peroxisomal proteins as compared to other organelle marker enzymes in rats treated with hypolipidemic agents.
Cherkaoui Malki M; Bardot O; Lhuguenot JC; Latruffe N
Biol Cell; 1990; 69(2):83-92. PubMed ID: 2271901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
